A database study on the real-world prescription status of mirogabalin in patients with peripheral neuropathic pain

A database study on the relationship between the dose titration pattern of mirogabalin prescription and adherence in patients with peripheral neuropathic pain - A database study on the real-world prescription status of mirogabalin in patients with peripheral neuropathic pain

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047313

Enrollment

2000

Registered

2022-03-31

Start date

2022-03-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral neuropathic pain

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients who were prescribed mirogabalin between March 1, 2020 and May 31, 2021 2.Patients with the diagnosis of peripheral neuropathic pain between the starting point and the index date on the database 3.Patients who were prescribed mirogabalin at least once within 45 days after the first prescription date

Exclusion criteria

Exclusion criteria: Patients who were prescribed mirogabalin at least once between the starting point and the first prescription date on the database

Design outcomes

Primary

Measure	Time frame
Medical possession ratio (MPR)	—

Secondary

Measure	Time frame
Proportion of days covered (PDC) Mirogabalin prescription continuation rate Rate of switching to other peripheral neuropathic pain drugs Prescription pattern of mirogabalin and other concomitant peripheral neuropathic pain drugs	—

Countries

Japan

Contacts

Public ContactKodama Sho

DAIICHI SANKYO CO., LTD. Primary Medical Science Department

kodama.sho.vc@daiichisankyo.co.jp03-6225-1053

Outcome results